Akebia Therapeutics Inc. (AKBA) at a glance

Akebia Therapeutics Inc. (AKBA) is a micro-cap Healthcare company. It trades at $0.87, with a -8.8% profit margin and revenue decline of 6.6%. It does not pay a dividend. Vestovix scores it 41/100 overall. Its strongest dimension is Safety (80/100) and its weakest is Momentum (14/100). It is a relatively defensive holding with below-market volatility.

Price

$0.87

Market cap

$248.0M

P/E ratio

n/a

Dividend yield

None

Beta

0.25

52-week range

$0.81 to $3.22